Skip to main content
Home / Current Pharmaceutical Biotechnology, Volume 1, Number 4
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 1, Number 4, 2000

Reviews

Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma
pp. 303-312(10)
Authors: White, C.A.; Berlfein, J.R.; Grillo-Lopez, A.J.

Favourites:
ADD

Controlled Delivery of Biotechnological Products
pp. 313-323(11)
Authors: Conti, S.; Polonelli, L.; Frazzi, R.; Artusi, M.; Bettini, R.; Cocconi, D.; Colombo, P.

Favourites:
ADD

Mitochondriotropic Cationic Vesicles A Strategy Towards Mitochondrial Gene Therapy
pp. 325-346(22)
Authors: Weissig, V.; Torchilin, V.P.

Favourites:
ADD

N-Glycosylation of Recombinant Pharmaceutical Glycoproteins Produced in Transgenic Plants Towards an Humanisation of Plant N-Glycans
pp. 347-354(8)
Authors: Lerouge, P.; Bardor, M.; Pagny, S.; Gomord, V.; Faye, L.

Favourites:
ADD

Structure Alteration of Polyketides by Recombinant DNA Technology in Producer Organisms Prospects for the Generation of Novel Pharmaceutical Drugs.
pp. 355-395(41)
Authors: Mendez, C.; Weitnauer, G.; Bechthold, A.; Salas, J.A.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content